Cognitive-driven ADL Impairment as a Predictor for PDD

CompletedOBSERVATIONAL
Enrollment

182

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

October 15, 2020

Study Completion Date

January 31, 2021

Conditions
Parkinson Disease
Interventions
DIAGNOSTIC_TEST

Functional Activities Questionnaire

The FAQ is an economic and easy to apply activity of daily living scale. We aim to validate the prognostic value of novel FAQ scores, which differentiate cognitive- from motor-driven activity of daily living function.

Trial Locations (1)

72076

University hospital of Tuebingen, Tübingen

All Listed Sponsors
collaborator

Sub-Investigator, Dr. Kathrin Brockmann, University Hospital of Tuebingen, Tuebingen, Germany

UNKNOWN

collaborator

Advisory board, Prof. Dr. Thomas Gasser, University Hospital of Tuebingen, Tuebingen, Germany

UNKNOWN

collaborator

Advisory board, Prof. Dr. Berg, Christian-Albrechts-University, Kiel, Germany

UNKNOWN

lead

University Hospital Tuebingen

OTHER

NCT03687203 - Cognitive-driven ADL Impairment as a Predictor for PDD | Biotech Hunter | Biotech Hunter